Literature DB >> 9241949

Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia.

K T Mueser1, R E Drake, T H Ackerson, A I Alterman, K M Miles, D L Noordsy.   

Abstract

The validity of subtypes based on antisocial personality disorder (APD) or childhood conduct disorder without adult APD (CD only) in patients with schizophrenia (or schizoaffective disorder) and a substance use disorder (abuse or dependence) was examined. APD patients scored lower on personality measures related to socialization and higher on antisocial behavior, psychopathy, and aggression. APD patients also reported higher rates of aggression and legal problems. APD, and to a lesser extent CD only, was associated with more severe psychiatric symptoms, an earlier age of onset of substance abuse, more severe symptoms of substance abuse, and a stronger family history of substance abuse and psychiatric hospitalization. The findings suggest that schizophrenia patients with APD represent a high-risk subgroup vulnerable to more severe substance abuse, psychiatric impairment, aggression, and legal problems.

Entities:  

Mesh:

Year:  1997        PMID: 9241949     DOI: 10.1037//0021-843x.106.3.473

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  14 in total

1.  Arrest types and co-occurring disorders in persons with schizophrenia or related psychoses.

Authors:  Patrick J McCabe; Paul P Christopher; Nicholas Druhn; Kristen M Roy-Bujnowski; Albert J Grudzinskas; William H Fisher
Journal:  J Behav Health Serv Res       Date:  2012-07       Impact factor: 1.505

2.  Case-management for patients with schizophrenia in Iran: a comparative study of the clinical outcomes of Mental Health Workers and Consumers' Family Members as case managers.

Authors:  Seyed Kazem Malakouti; Marzieh Nojomi; Lili Panaghi; Narjes Chimeh; Yasaman Mottaghipour; Mohammad Taghi Joghatai; Ahmad Ali Noorbala; Jafar Bolhari
Journal:  Community Ment Health J       Date:  2009-12

3.  Antisocial Personality Disorder in People with Co-Occurring Severe Mental Illness and Substance Use Disorders: Clinical, Functional, and Family Relationship Correlates.

Authors:  Kim T Mueser; Jennifer D Gottlieb; Corrine Cather; Shirley M Glynn; Roberto Zarate; Lindy F Smith; Robin E Clark; Rosemarie Wolfe
Journal:  Psychosis       Date:  2012-01-01

Review 4.  The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.

Authors:  John H Krystal; D Cyril D'Souza; Jürgen Gallinat; Naomi Driesen; Anissa Abi-Dargham; Ismene Petrakis; Andreas Heinz; Godfrey Pearlson
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

5.  Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders.

Authors:  Kim T Mueser; Anne G Crocker; Linda B Frisman; Robert E Drake; Nancy H Covell; Susan M Essock
Journal:  Schizophr Bull       Date:  2006-03-30       Impact factor: 9.306

6.  Resting EEG deficits in accused murderers with schizophrenia.

Authors:  Robert A Schug; Yaling Yang; Adrian Raine; Chenbo Han; Jianghong Liu; Liejia Li
Journal:  Psychiatry Res       Date:  2011-08-06       Impact factor: 3.222

7.  A comparison of schizophrenic patients with or without coexisting substance use disorder.

Authors:  Coreen Farris; Christiane Brems; Mark E Johnson; Rebecca Wells; Randall Burns; Nicholas Kletti
Journal:  Psychiatr Q       Date:  2003

Review 8.  [Dual diagnosis of psychosis and addiction. From principles to practice].

Authors:  E Gouzoulis-Mayfrank
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

9.  Program planning and staff competencies for forensic assertive community treatment: ACT-eligible versus FACT-eligible consumers.

Authors:  Gary S Cuddeback; Joseph P Morrissey
Journal:  J Am Psychiatr Nurses Assoc       Date:  2011 Jan-Feb       Impact factor: 2.385

10.  Different needs in patients with schizophrenia spectrum disorders who behave aggressively towards others depend on gender: a latent class analysis approach.

Authors:  Moritz Philipp Günther; Steffen Lau; Sabine Kling; Martina Sonnweber; Elmar Habermeyer; Johannes Kirchebner
Journal:  Ann Gen Psychiatry       Date:  2021-03-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.